ENvue Medical (FEED) Operating Income Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | -52.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.08% |
| Dec 31, 2025 | -105.46% |
| Sep 30, 2025 | -34.48% |
| Jun 30, 2025 | -46.37% |
| Mar 31, 2025 | -18.53% |
| Dec 31, 2024 | 18.28% |
| Sep 30, 2024 | -3.77% |
| Jun 30, 2024 | 12.06% |
| Mar 31, 2024 | 24.39% |
| Dec 31, 2023 | 23.04% |
| Sep 30, 2023 | 5.90% |
| Jun 30, 2023 | 11.75% |
| Mar 31, 2023 | -5.17% |
| Dec 31, 2022 | -11.29% |
| Sep 30, 2022 | -5.23% |
| Jun 30, 2022 | -12.27% |
| Mar 31, 2022 | 20.62% |
| Dec 31, 2021 | -22.57% |
| Sep 30, 2021 | 13.17% |
| Jun 30, 2021 | -6.30% |
| Mar 31, 2021 | -18.48% |
| Dec 31, 2020 | -14.83% |
| Sep 30, 2020 | -9.46% |
| Jun 30, 2020 | -30.54% |
| Mar 31, 2020 | -4.19% |
| Dec 31, 2019 | -13.79% |
| Sep 30, 2019 | -13.32% |
| Jun 30, 2019 | -25.25% |
| Mar 31, 2019 | -67.39% |
| Dec 31, 2018 | -43.63% |
| Sep 30, 2018 | -57.72% |
| Jun 30, 2018 | -37.84% |
| Mar 31, 2018 | -36.44% |
| Dec 31, 2017 | -53.53% |
| Sep 30, 2017 | -5.77% |
| Jun 30, 2017 | -35.04% |
| Mar 31, 2017 | -96.35% |